Stock Detail
TRANSCEPT PHARMACEUTICALS INC
Sector: Biotechnology
Latest Quote @ Wed Jun 6 19:07:03 (15 min delayed)
| $1.50 |
$3.73 |
$3.05 |
+0.03 |
0.99% |
|
Last Day's Data
| $3.02 |
$3.02 |
$0.06 |
2.03% |
0.00 |
$2.96 |
| $2.99 |
$2.98 |
242,570.00 |
56.64M |
116,682.00 |
0.00 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 3.05 |
3.04 |
3.01 |
3.00 |
2.97 |
Stock Profile
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. Its lead product candidate, Intermezzo, a sublingual low dose formulation of zolpidem used for sleep aid has completed Phase III clinical trial. The company is headquartered in Point Richmond, California.
